One Organization's Panic is an Other Organization's Profit With the swine flu pandemic grabbing headlines and scaring countries the world over, GlaxoSmithKline says that it expects to reap up to $2.1 billion next year from the sale of a new H1N1 vaccine. And it's already … [Read more...] about $2.1B Swine Flu Vaccination Serum Windfall for Glaxo